Speaker illustration

Doctor Yanina Lenz

Berlin (Germany)

Renal decline in patients with atrial fibrillation treated with rivaroxaban or warfarin: a population-based cohort study in the United Kingdom

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiplatelet Drugs

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb